Science

Agamon’s AI software trains hospital computers to 'read' a doctor’s unique clinical language and transform it into structured data.

The Rehovot-based firm said it completed the manufacturing of the first batch of its plasma-derived IgG product for the novel coronavirus.

Scientists will send experiments into space, including a capsule of E. coli, with the hope of overcoming antibiotic-resistant germs and to prepare for space travelers getting sick.

A newly published study of cow and goat milk samples found low levels of residues but there is still cause for concern, the researchers say.

Founded in 2014, Clew developed an AI analytics platform to help providers make better-informed clinical decisions by predicting life-threatening complications.

Clinical trials for the potential treatment and prevention of COVID-19 using medical cannabis are scheduled to begin at Rambam Health Care Campus in the next few months.

25 Israeli startups were selected for the inaugural IP² LaunchPad which will provide companies with exposure to East Asian markets.

This is the first time such an endeavor of converting redundant public phone booths into lifesaving devices has been done on a national level

The company’s sugar reduction product, Incredo, can lower the amount of sugar present in a variety of foods from anywhere between 30-50 percent.

The company developed breakthrough radiation cancer therapy and is embarking on a number of new of clinical trials.

Israeli medical diagnostics startup MeMed Diagnostics has received a CE Mark clearance for its pioneering diagnostic test MeMed BV and point-of-need platform MeMed Key. Founded in 2009, MeMed has built a diagnostic tool for distinguishing between bacterial and viral infections like the coronavirus. The company is now also developing a diagnostics test for early detection […]

The tunnel is placed at the VIP entrance to Bloomfield Stadium as part of a pilot program.

Interreg Germany-Denmark’s Changing Cancer Care initiative launches study to assess PixCell Medical’s HemoScreen hematology analyzer for home-based blood testing.

Researchers at the Israel Institute for Biological Research (IIBR) say that a combination of two existing antiviral drugs appear to inhibit the growth of SARS CoV-2.

The company that connects travelers and doctors saw a 150% increase in its telemedcine virtual network in the last two months.